SCHEMBL15533384

SCHEMBL15533384

O=C(O)c1ccccc1N1CCC(O)CC1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
ALOX15 P16050 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
GAA P10253 1/20 0.48
NPC1 O15118 1/20 0.47
PTPN1 P18031 2/20 0.47
MYC P01106 4/20 0.46
NR4A1 P22736 1/20 0.46
HRH1 P35367 1/20 0.46
CCR3 P51677 1/20 0.46
KCNH2 Q12809 1/20 0.46
ENPP2 Q13822 2/20 0.45
CPB1 P15086 1/20 0.44
NOTUM Q6P988 1/20 0.44
POLB P06746 1/20 0.44
APEX1 P27695 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
KMT2A Q03164 1/20 0.43
MLYCD O95822 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27676401 0.86 ALDH1A1 (0.48) ALDH1A1ALOX15L3MBTL1GAANPC1
SCHEMBL6829549 0.86 NOTUM (0.51) ALDH1A1ALOX15L3MBTL1GAANPC1
SCHEMBL9178263 0.85 ALDH1A1 (0.50) ALDH1A1ALOX15L3MBTL1GAANPC1
SCHEMBL8048603 0.85 ALDH1A1 (0.61) ALDH1A1ALOX15L3MBTL1NPC1PTPN1
SCHEMBL6650052 0.85 KMT2A (0.60) ALDH1A1ALOX15L3MBTL1GAANPC1
SCHEMBL3084334 0.85 NPC1 (0.68) ALDH1A1ALOX15GAANPC1NOTUM
SCHEMBL29627850 0.84 NOTUM (0.50) ALDH1A1ALOX15L3MBTL1GAAPTPN1
SCHEMBL28691758 0.83 NOTUM (0.49) ALDH1A1ALOX15L3MBTL1GAAPTPN1
SCHEMBL1097070 0.82 HTR6 (0.50) ALDH1A1L3MBTL1NPC1PTPN1NR4A1
SCHEMBL29467270 0.82 NPC1 (0.68) ALDH1A1ALOX15L3MBTL1GAANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4217350-A1 BENZOTHIAZOLE AND QUINOLINE DERIVATIVES AND THEIR USE Shanghai Yao Yuan Biotechnology Co., Ltd. (CN) 2023-08-02 EP disclosed
WO-2013175281-A1 USE OF SUBSTITUTED 2-PHENYL-3H-QUINAZOLIN-4-ONES AND ANALOGS FOR INHIBITING BROMODOMAIN AND EXTRA TERMINAL DOMAIN (BET) PROTEINS RVX THERAPEUTICS INC. (CA) 2013-11-28 WO disclosed